
Bain, Cinven amend takeover offer for Stada
Bain Capital Private Equity and Cinven Partners have extended the acceptance period and lowered the acceptance threshold of their public takeover offer for Germany-based pharmaceutical company Stada.
The acceptance period has been extended from 8 June to 22 June and the acceptance threshold reduced from 75% to 67.5%. The current acceptance rate is 21.5%.
The action is due to a lower-than-expected level of tender participation by retail investors, according to a statement. In addition, the statement notes that some index funds are unable to tender their shares during the original period.
The bidder is confident that the transaction certainty will be increased by this amendment. All other offer conditions remain unchanged.
Bain and Cinven's takeover bid was approved by management in April at a price of €66 per share, valuing the company at €5.3bn after outbidding rival consortium Advent and Permira in an auction.
Latest News
Stonehage Fleming raises USD 130m for largest fund to date, eyes 2024 programme
Multi-family office has seen strong appetite, with investor base growing since 2016 to more than 90 family offices, Meiping Yap told Unquote
Permira to take Ergomed private for GBP 703m
Sponsor deploys Permira VIII to ride new wave of take-privates; Blackstone commits GBP 200m in financing for UK-based CRO
Partners Group to release IMs for Civica sale in mid-September
Sponsor acquired the public software group in July 2017 via the same-year vintage Partners Group Global Value 2017
Change of mind: Sponsors take to de-listing their own assets
EQT and Cinven seen as bellweather for funds to reassess options for listed assets trading underwater